't zal maar gebeuren schreef op 11 februari 2016 11:54:
Analysts Expect Pharming Group (NASDAQ:PHGUF) to Announce $0.00 EPS
February 11th, 2016 - 0 comments - Filed Under - by Preston Daniels
Pharming Group logoPharming Group (NASDAQ:PHGUF) has received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.
Zacks has also assigned Pharming Group an industry rank of 61 out of 265 based on the ratings given to its competitors.
Shares of Pharming Group (NASDAQ:PHGUF) opened at 0.35 on Monday. The stock has a market capitalization of $142.90 million and a PE ratio of 17.50. The firm’s 50 day moving average price is $0.00 and its 200-day moving average price is $0.00.
Separately, Zacks Investment Research upgraded shares of Pharming Group from a “hold” rating to a “buy” rating and set a $0.50 target price for the company in a report on Wednesday, November 4th.
Pharming Group NV (NASDAQ:PHGUF) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies.